11:24 AM EDT, 04/04/2024 (MT Newswires) -- Grifols ( GRFS ) said Thursday its new Procleix ArboPlex assay got the EU's CE mark under the In Vitro Diagnostic Regulation.

The assay is an automated nucleic acid test validated for screening blood donors to detect chikungunya, dengue, West Nile, and Zika viruses, the company said.

The test uses plasma or serum samples to detect arboviral ribonucleic acid, or RNA, and can help cut the risk of transfusion-transmitted infections, the company added.

The assay is set to be available in markets accepting the CE mark certification after any additional registration and notification, Grifols ( GRFS ) said.

Shares of the company rose 2.2% in recent trading Thursday.

Price: 7.04, Change: +0.15, Percent Change: +2.18